Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology, immunoserology, chemistry, hematology, and coagulation. Further, it provides medical equipment, pain management, endoscopy system, digestive health, cardiology, vasuclar interventions, radiology, care wards, radiotherapy, urology, ophtalmology, anesthesia, respiratory care, endoscopy system and digestive health, and woman health services; oncogenetics, pharmacogenetics, and pregnancy check, genetic diseases testing services. Additionally, the company offers single cell analysis, microbiome, epigenetics, gene expression, bioinformatics, molecular diagnostics, automated and manual DNA/RNA, and liquid biopsy solutions. Furthermore, it provides Vento2ux and Flight 60, a clinical ventilation product. Ilex Medical Ltd was founded in 1977 and is based in Petah Tikva, Israel.
Metrics to compare | ILX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipILXPeersSector | |
---|---|---|---|---|
P/E Ratio | 18.3x | 19.7x | −0.7x | |
PEG Ratio | −0.54 | 0.61 | 0.00 | |
Price/Book | 1.5x | 2.6x | 2.6x | |
Price / LTM Sales | 1.0x | 1.8x | 3.2x | |
Upside (Analyst Target) | - | 5.9% | 47.0% | |
Fair Value Upside | Unlock | 2.7% | 7.5% | Unlock |